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Summary
 
Neisseria gonorrhoeae
 
 (
 
Ngo
 
), the etiologic agent of gonorrhea, induce a number of proinflamma-
tory cytokines by contact to epithelial cells. Cytokine genes and a variety of other immune re-
sponse genes are activated as a result of the regulatory function of immediate early response
transcription factors including activator protein 1 (AP-1). Since it is established that phosphory-
lation of c-Jun, the central component of AP-1, by the stress-activated c-Jun NH
 
2
 
-terminal ki-
nase (JNK) increases the transcriptional activity of AP-1, we studied whether 
 
Ngo
 
 could induce
stress response pathways involving JNK. We found that virulent 
 
Ngo
 
 strains induce phosphory-
lation and activation of JNK but not of p38 kinase. Analysis of a nonpathogenic 
 
Ngo
 
 strain re-
vealed only weak JNK activation. In respect to the molecular components upstream of the
JNK signaling cascade, we show that a dominant negative mutant of MAP kinase kinase 4
(MKK4) represses transcription of an AP-1–dependent reporter gene. Regarding upstream
stress response factors involved in 
 
Ngo
 
-induced MKK4/JNK/AP-1 activation, we identified
p21-activated kinase (PAK) but not MAPK/ERK kinase kinase (MEKK1). Inhibition of small
GTPases including Rac1 and Cdc42 by Toxin B prevented JNK and AP-1 activation. Our re-
sults indicate that 
 
Ngo
 
 induce the activation of proinflammatory cytokines via a cascade of cel-
lular stress response kinases involving PAK, which directs the signal from the Rho family of
small GTPases to JNK/AP-1 activation.
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T
 
he production of immunostimulatory cytokines by ep-
ithelial cells is an essential part of the biological re-
sponse to the infection with human pathogenic microor-
ganisms (1). Any inflammatory reaction requires the de
novo synthesis of defined proteins. These include chemo-
kines that attract macrophages and inflammatory cytokines
that serve to amplify and spread the primary pathogenic
signal. The mechanism by which these proteins are newly
synthesized involves an inducible transcriptional initiation
of their respective genes. This is governed by several tran-
scription factors playing a role in regulating immune re-
sponse genes including the early transcription factor activa-
tor protein 1 (AP-1; reference 2).
 
1
 
Human pathogenic 
 
Neisseria gonorrhoeae
 
 (
 
Ngo
 
) induce a
number of cytokine genes in epithelial cells involving the
activity of the transcription factor AP-1 (3). The natural
host benefit of cytokine release in response to pathogen in-
fection is exploited by 
 
Ngo
 
 which cause a massive localized
inflammation characterized by the infiltration of polymor-
phonuclear leukocytes and mononuclear phagocytes into
the infected tissue of the urethra or the endocervix (4). As a
consequence, the infected epithelial cell layer is destroyed
and the bacteria may gain better access to deeper tissues (5).
The colonization of the epithelia is a prerequisite of infec-
tion by 
 
Ngo
 
 and is largely dependent on the expression of a
set of variable surface proteins. The hair-like type 4 pili
 
protein; MAPK, MAP kinase; MEK, MAP/ERK; MEKK, MEK kinase;
MKK, MAPK kinase; MKKK, MKK kinase; MOI, multiplicities of infec-
tion; NF-
 
k
 
B, nuclear factor 
 
k
 
B; 
 
Ngo
 
, 
 
Neisseria gonorrhoeae
 
; PAK, p21-acti-
vated kinase; PLC, phosphatidylcholine–dependent phospholipase C;
SAPK, stress-activated protein kinase.
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Abbreviations used in this paper:
 
 AP-1, activator protein 1; ASM, acidic
sphingomyelinase; CRIB, Cdc42/Rac interactive binding; DAG, di-
acylglycerol; DN, dominant negative; EGF, epidermal growth factor;
ERK, extracellular signal-regulated kinase; HSP, heparan-sulfate pro-
teoglycan; JNK, c-Jun NH
 
2
 
-terminal kinase; MAP, mitogen-activated
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mediate the first contact between bacteria and host cells
and are indispensable for infection in vivo (6, 7). Variant
outer membrane proteins of the opacity-associated outer
membrane protein family (Opa proteins) tightly interact
with the host cell surface and trigger the engulfment of 
 
Ngo
 
(8). There are at least three independent routes by which
opa proteins induce the uptake of 
 
Ngo
 
 into host cells each
mediated by interaction with a certain receptor. Heparan-
sulfate proteoglycan (HSP) receptors (9) or the concerted
action of HSPR and integrin receptors (10, 11) account for
the major pathways for uptake into epithelial cells. Uptake
of 
 
Ngo
 
 by the HSPR pathway involves the action of phos-
phatidylcholine-dependent phospholipase C (PLC) and the
acidic sphingomyelinase (ASM; reference 12), the HSPR–
integrin pathway possibly PKC (11). In phagocytic cells,
Opa proteins occupy receptors of the CD66 family that re-
sults in a rapid, opsonin-independent phagocytosis of 
 
Ngo
 
(13–15) involving Src kinases and Rac1 (16).
In contrast to the well-studied 
 
Neisseria
 
 adherence and
invasion process, very little is known about the nature of
the pathogen-induced proinflammatory signals. Our previ-
ous results showed that the infection of epithelial cells with
gonococci induced the activation of the transcription factor
AP-1 (3). In line with the known immunostimulatory
function of AP-1 and nuclear factor 
 
k
 
B (NF-
 
k
 
B; references
17, 18) epithelial cells infected with 
 
Ngo
 
 produced in-
creased amounts of numerous proinflammatory cytokines
(3). The secretion of cytokines in the cultured epithelial
cell model was not initiated by LPS suggesting that the en-
dotoxin-mediated mechanisms known to trigger inflamma-
tory reactions of lymphoid cells are not relevant for epithe-
lial cells (3). However, neither the signals nor the signaling
pathways activating AP-1, which lead to production of cy-
tokines in 
 
Ngo
 
-infected epithelial cells, are defined.
Environmental stress or engagement of cytokine recep-
tors leads to the activation of AP-1 and a family of mito-
gen-activated protein kinases (MAPK), which consecu-
tively activate their members by phosphorylation (18, 19).
In such a cascade, the AP-1 subunit c-Jun is activated by
the c-Jun NH
 
2
 
-terminal kinase (JNK); JNK itself is acti-
vated by MAPK kinase 4 and 7 (MKK4, MKK7); and
MKK4 is activated by MAP/ERK (extracellular signal–reg-
ulated kinase) kinase 1 (MEKK1) at the level of MAPK,
MKK, and MKK kinase (MKKK), respectively. Numerous
MKKK beside MEKK1 have recently been identified, all
able to activate the JNK pathway (20–25). The reason why
mammalian cells express so many MKKK involved in sig-
naling to stress-activated transcription factors is still un-
known. It is still unclear in particular how the MKKK
themselves are activated in mammalian cells in response to
stress signals or cytokine receptor activation.
The small GTPases Rac1 and Cdc42 have been identified
as far upstream regulators of the JNK-kinase cascade (20,
26, 27). The p21-activated kinases (PAKs) were the first
kinases identified as direct effectors for the active GTPases
Rac1 and Cdc42 (28). GTP-loaded Rac1 or Cdc42 bind to
a Cdc42/Rac interactive binding (CRIB) domain (29) and
thereby increase the activity of PAK significantly (28). Re-
 
cently, MEKK1 and MEKK4 have also been shown to inter-
act with Rac and Cdc42 (30). Blocking either PAK or
MEKK1 activity prevents the activation of JNK either in re-
sponse to activated GTPases (30, 31) or to apoptotic stimuli
independent of GTPases (32, 33). However, blocking MEKK
kinase does not prevent JNK activation by active PAK
suggesting that both classes of kinases signal independently.
Here we show that 
 
Ngo
 
 induces the activation of the
AP-1 transcription factor by a distinct kinase cascade in-
volving GTPases, PAK, MKK4, and JNK1, but not MEK
kinase 1. The identification of pathogen-specific signaling
pathways to inflammatory cytokine production might be a
basis for the therapeutic intervention of infections.
 
Materials and Methods
 
Human Cell Culture and Infection.
 
Epithelial cells (HeLa and
Chang) were grown in RPMI 1640 (GIBCO BRL, Gaithers-
burg, MD) supplemented with 4 mM glutamine, 100 U/ml pen-
icillin, 100 
 
m
 
g/ml streptomycin, and 10% FCS in a humidified
5% CO
 
2
 
 atmosphere. Epithelial cells were seeded in tissue culture
plates for 48 h before infection. 16 h before infection, the me-
dium was replaced by fresh RPMI 1640 medium supplemented
with 10% FCS. The epithelial cells were infected with 
 
Ngo
 
 given
in multiplicities of infection (MOI) as described in the figure leg-
ends for different periods of time. For infection experiments, bac-
teria were centrifuged onto the epithelial cell monolayer for 5 min
at 500 
 
g
 
. In the experiments using 10–50 ng/ml Toxin B (sup-
plied by F. Hofmann and K. Aktories, University of Freiburg,
Freiburg, Germany), the cells were preincubated for 15 min be-
fore the bacteria were added. Stimulation of the cells with 10 ng/
ml TNF-
 
a
 
 (Promega, Heidelberg, Germany) or 50 nM PMA
(Sigma Chemical Co., St. Louis, MO) was performed for the in-
dicated time points.
 
Bacteria.
 
Three different 
 
Ngo
 
 strains were used for infection
of human epithelial cell lines: the nonpiliated, but invasive Opa
 
1
 
strain N242, (VP1, P.IA, P
 
2
 
, Opa
 
27
 
, Opa
 
27.5
 
, Opa
 
28
 
, Opa
 
29
 
,
Opa
 
30
 
, lipopolysaccharide type L1) has been described (8). The
adherent but noninvasive P
 
1
 
 strain N138 (P
 
1
 
 PilE
 
F3
 
) and the P
 
2
 
Opa
 
2
 
 control strain N300 (PilE
 
B1
 
, 
 
opaC
 
30
 
::
 
cat
 
, pTH7) are deriva-
tives of strain MS11 (34, 35). Gonococci were routinely grown
on GC phosphate agar as described previously (36). Strain N242
was also grown in RPMI 1640 containing 25 mM Hepes, pH
7.2, for 2 h at 37
 
8
 
C before infection.
 
Transfections and Luciferase Reporter Assays.
 
To measure the trans-
activating activity of AP-1, HeLa cells at 50–70% confluence
were cotransfected by cationic liposomes (Promega) with 1 
 
m
 
g of
a luciferase expression plasmid containing three repeats of the
AP-1 binding site as an enhancer element and expression con-
structs: dominant negative MEKK1 (K432M), dominant negative
(DN) MKK4 (K116R, DNJNKK), DNPAK1 (K299R), PAK2
(K278R) or PAK1 (H83L, H86L, and K299R), or wild-type
PAK2 or PAK1. 24 h after transfection, cells were left untreated,
infected with 
 
Ngo
 
 strains, treated with 50 nM PMA, or preincu-
bated with Toxin B. Luciferase assays were performed at the indi-
cated time points as recommended by the manufacturer’s instruc-
tions (Promega). The results were recorded on a Wallac 409
 
b
 
-counter (Berthold-Wallac, Bad Wildbad, Germany), and given
as fold induction against untreated cells. The data presented are
representative of more than three separate experiments.
 
Immunoprecipitation, Immunoblotting, and Protein Kinase Assays.
 
To assess the kinase activity of JNK and p38, cells were lysed in 
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RIPA buffer as described previously (37). For PAK, cells were
lysed in 50 mM Tris, pH 7.5, 1 mM EGTA, 5 mM MgCl
 
2
 
, 1%
NP-40, 2.5% glycerol, 150 mM NaCl, 1 mM Na
 
3
 
VO
 
4
 
, 10 mM
Na
 
4
 
P
 
2
 
O
 
4
 
, 50 mM NaF, 100 
 
m
 
M PMSF, 10 
 
m
 
M Pepstatin A, and
4 
 
m
 
M Aprotinin. The cells were disrupted by passing the lysate
several times through a 21-gauge syringe. The cell debris was col-
lected by centrifugation and the supernatant was subsequently in-
cubated with appropriate antisera (Santa Cruz Biotechnology,
Santa Cruz, CA) coupled to protein A– or G–Sepharose (Amer-
sham Biotechnology Inc., Piscataway, NJ). The antisera were
coupled to the protein A or G beads in PBS for 1 h at 4
 
8
 
C. In a
first preadsorption step the supernatants were incubated with pro-
tein A or G beads alone for 1 h at 4
 
8
 
C. After this preadsorption
the supernatants were incubated with the appropriate antisera for
2–3 h at 4
 
8
 
C. Immunocomplexes were recovered and washed
several times with RIPA buffer and twice with kinase buffer. Im-
munoprecipitates of JNK were resuspended in 30 
 
m
 
l of kinase
buffer containing 100 mK KCl, 0.1 mM CaCl
 
2
 
, 6 mM MgCl
 
2
 
, 30
mM Tris, pH 7.5, 0.1 mM Na
 
3
 
VO
 
4
 
, 10 mM K
 
2
 
HPO
 
4
 
, 10 mM
NaF, 1 mM DTT, and 1 
 
m
 
g of the substrate (GST–c-Jun for
JNK, GST-ATF2 for p38; Santa Cruz Biotechnology). Immuno-
precipitates of PAK were resuspended in 30 
 
m
 
l of kinase buffer
containing 50 mM Hepes, pH 7.5, 10 mM MgCl
 
2
 
, 2 mM
MnCl
 
2
 
, 0.2 mM dithiothreitol, 0.1 mM Na
 
3
 
VO
 
4
 
, 14 
 
m
 
M ATP,
and 1 
 
m
 
g of myelin basic protein (MBP; Sigma Chemical Co.).
The kinase reactions were initiated by addition of 10 
 
m
 
Ci
 
g
 
-[
 
32
 
P]ATP (5,000 Ci/mmol; Amersham Pharmacia Biotechnol-
ogy Inc.). After 30 min incubation at 30
 
8
 
C, reactions were termi-
nated by adding SDS loading buffer. Samples were separated by
SDS-PAGE, blotted, and developed as described (38) to show
similar protein amounts in all lanes. After immunostaining the
blots were analyzed further by autoradiography or PhosphorIm-
ager analysis.
 
Results
 
Activation of JNK in Response to Ngo–Epithelial Cell Contact.
 
In our previous report, we showed that the early response
transcription factor AP-1 and inflammatory cytokine gene
expression are coordinately induced in 
 
Ngo
 
 infected epithe-
lial cells (3). Activation of the dimeric sequence specific en-
hancer factor AP-1 is mediated through phosphorylation of
c-Jun by members of the MAPK family. Therefore, we ex-
amined whether the JNKs and/or p38, also known as stress
activated kinases (39–41) are involved in the signaling lead-
ing to 
 
Ngo
 
-induced AP-1 activation and inflammatory cy-
tokine gene expression. Cell lysates from 
 
Ngo
 
-infected epi-
thelial cells were used at different time points after infection
for immunoprecipitation of the endogenous kinases and
solid-phase kinase assays using appropriate substrates were
performed.
The 
 
Ngo
 
 strains tested differed with regard to the infec-
tion of epithelial cells. Strain N138 (P
 
1
 
 Opa
 
2
 
) expresses
pili that confer adherence to epithelial cells, but does not
express any Opa proteins and therefore is not invasive (42).
Strain N242 (Opa1) enters epithelial cells by binding to
heparan sulfate containing surface proteoglycan receptor
proteins (8, 9). Strain N300 (P2 Opa2) is neither piliated,
nor does it express Opa proteins (35) and, hence, is a very
weak adherent. Infection with Ngo strains was routinely
monitored by light microscopy.
The activity of JNK1 was induced several fold in sub-
confluent monolayers of HeLa cells by adherence of Ngo
strain N138 (P1 Opa2; Fig. 1, top) within 15 min after in-
fection. The immediate JNK1 induction was followed by a
sustained JNK1 kinase activation for at least 90 min. Acti-
vation of JNK1 in Chang epithelial cells was at least 10
times weaker than in HeLa cells, probably due to lower
adherence levels of Ngo to Chang cells. To test whether
cellular JNK1 activation is at variance in epithelial cells
infected with adherent versus invasive Ngo strains, we com-
pared JNK1 kinase activity in HeLa cells and Chang cells
infected either with the P1 or Opa1 strain. At a MOI of
50, the invasive Opa1 strain induced a slightly stronger ac-
tivation of JNK1 activity than the P1 strain, whereas weak
JNK1 activation was observed in cells treated with the
nonpathogenic strain N300 (P2 Opa2) or LPS. The activa-
tion of JNK1 in response to Ngo was delayed compared to
the JNK1 induction in TNF-a–treated cells, but showed a
similar potential to induce JNK1 activity. The lower panel
shows a Western blot probed with an anti-JNK1 antibody,
to show similar protein amounts in all lanes. Weak activa-
tion of JNK2 was observed in HeLa cells in response to
Ngo infection (data not shown). In contrast to JNK1, we
did not detect any p38 induction paralleled with JNK1 ac-
tivation (data not shown).
DNMKK4 Inhibits Ngo-mediated Induction of AP-1. Be-
sides the various stimuli (growth factors, UV light irradia-
tion, cytokines, protein synthesis inhibitors, etc.) that could
induce the JNK cascade (19), pathogens represent new po-
Figure 1. Ngo-induced JNK1 activation of epithelial cells. HeLa (lanes
1–4) or Chang (lanes 5–8) cells were infected either with different Ngo
strains (P1 Opa2, P2 Opa1, and P2 Opa2) at a MOI of 50, or stimulated
with 10 ng/ml TNF-a or 10 mg/ml LPS at 378C. JNK1 was immuno-
precipitated with an anti-JNK1 (Santa Cruz, sc-474) antibody and immu-
nocomplex kinase activity (p-JNK1) was determined by phosphorylation
of the substrate GST-c-Jun (amino acids 1–79). First, the samples were
separated by SDS-PAGE, blotted and the Western blots probed with the
anti-JNK1 antibody, to show similar protein amounts in all lanes. One
representative Western blot for each cell line is shown (bottom). The
JNK1 protein is indicated. In the subsequent autoradiography the JNK1
kinase activity (p-JNK1) measured by c-Jun substrate phosphorylation is
indicated (top). The data are representative for at least three independent
experiments.1280 Activation of Stress Response Kinases by N. gonorrhoeae
tent inducers in this regard. Thus it is a challenge to under-
stand whether pathogens inducing inflammation use similar
or different signaling pathways compared to known stimuli.
For JNK, MKK4/SEK1 (stress-activated protein kinase/
extracellular-regulated kinase 1 [SAPK/ERK]) has been
identified as a direct activator, phosphorylating JNK at
threonine and tyrosine residue in the motif TPY (43–45).
In addition, recent studies using sek12/2 cells indicated that
there are MKK4/SEK1-dependent and MKK4/SEK1-
independent signaling pathways for JNK activation (46, 47).
To address the possible role of MKK4 in Ngo-induced
transcriptional activity of AP-1, we examined the effect of
inhibitory DNMKK4 on the transcription of an AP-1–
dependent reporter construct (Fig. 2). In transient transfec-
tion assays the overexpressed DNMKK4 significantly in-
hibited P1 Opa2 and P2 Opa1 induced AP-1–dependent
reporter gene expression (Fig. 2, A and B), but not of an
NF-kB–dependent reporter gene (data not shown). This is
in agreement with the earlier observation that the JNK ac-
tivation is not linked to NF-kB activation (48, 49). Simi-
larly, PMA induced AP-1 activation was blocked by
DNMKK4 (Fig. 2 D). Ngo strain P2 Opa2 did not induce
AP-1 transactivation activity (Fig. 2 C). The strong inhibi-
tory effect of DNMKK4 on pathogenic Ngo and PMA in-
duced AP-1 activation indicates a major role of MKK4 for
the JNK-MAPK signal transduction pathway. DNMKK4
might inhibit Ngo-induced signal transduction pathways, in
which MKK4 is intimately involved by strongly interacting
with its upstream activators and/or its downstream ele-
ments.
Toxin B Inhibits AP-1 and JNK Activation in Ngo-stimulated
Cells. Attachment of epithelial cells by Ngo suggests the
involvement of cytoskeletal rearrangements (36) as shown
for Helicobacter pylori (50) and other pathogenic microbes
(51). Cytoskeletal rearrangements are known to be regu-
lated by small GTPases of the Rho family (52). Therefore,
we studied whether GTPases were involved in Ngo-
induced signaling pathways leading to JNK and AP-1 acti-
vation. The GTPases Rac1 and Cdc42 have been identified
as important intermediates to the JNK signaling cascades
(20, 27, 53). The activity of Rho GTPases but not of Ras is
specifically inhibited by enterotoxin Toxin B from Clostrid-
ium difficile, which glycosylates and inactivates Cdc42,
Rac1, and Rho (54, 55). Pretreatment of HeLa cells for 15
min with 10 ng/ml Toxin B is sufficient to reduce AP-1
transactivation activity in the presence of adherent Ngo
strain (P1 Opa2) to the baseline levels (Fig. 3, compare
right and left panel) indicating the involvement of Rho-
GTPases in Ngo-induced AP-1 activation. As a control we
studied the PMA-induced AP-1–dependent reporter activ-
ity, which appears not to be affected by Toxin B (Fig. 3).
Similarly to AP-1, JNK activation (assayed in an in vitro
kinase assay) in response to the adherent Ngo strain (P1
Opa2) was inhibited in the presence of Toxin B (Fig. 4,
lanes 1 and 3 versus 4 and 6). Treatment of HeLa cells with
Toxin B already induces JNK activity (Fig. 4, lanes 1 and
4). In contrast to Ngo, PMA-stimulated cells could induce
JNK activity in Toxin B–treated cells (Fig. 4, lanes 1, 2, 4,
and 5).
AP-1 Activation in Ngo-stimulated Epithelial Cells Involves
PAK Signaling. There are potentially many different ki-
nases that could contribute to small GTPase-mediated JNK
and AP-1 activation. The most prominent kinases acting
downstream of Rho-GTPases are the PAKs (p21-activated
kinases) and the MEKK (56). The PAKs show homology
to STE20p (28), which mediate specific responses involv-
ing Cdc42p in S. cerevisiae (57). In analogy to S. cerevisiae,
it was suggested that PAKs are intermediate in Cdc42/
Figure 2. Inhibition of AP-1 transactivation activity by dominant in-
hibitory MKK4. HeLa cells were transfected with 1 mg reporter construct
containing three repeats of the AP-1 binding site and either 1 mg domi-
nant inhibitory MKK4 (DNMKK4) or empty vector. After overnight in-
cubation with the DNA, cells were infected with different Ngo strains (P1
Opa2, P2 Opa1, and P2 Opa2; A–C) at a MOI of 50 or treated with 50 nM
PMA (D) for the indicated periods of time. The results of a representative
experiment are expressed as fold induction compared with the activity
observed with transfection of the reporter vector and empty vector, and
in the absence of Ngo strains or PMA. Similar results were obtained in
more than three independent experiments.
Figure 3. Toxin B inhibits
Ngo-stimulated AP-1 activation.
HeLa cells were transfected with
1 mg reporter construct and after
overnight incubation, cells were
treated with 10 ng/ml Toxin B
15 min before the infection with
Ngo strain P1 Opa2 at a MOI of
50, or with 50 nM PMA for 30
min, respectively (right). As a
control, cells were left without
Toxin B (left). The results from a
representative experiment are
expressed as fold induction com-
pared with the activity observed
with transfection of the reporter vector and in the absence of Toxin B,
Ngo or PMA. Similar results were obtained in more than three indepen-
dent experiments.1281 Naumann et al.
Rac1-mediated activation of MEKK (26, 27). Recent re-
sults show that MEKK1 directly interacts with Rac1 and
Cdc42 (30), indicating that PAK and MEKK1 indepen-
dently associate with Rho-GTPases. To examine whether
PAK or MEKK1 are involved in transcriptional responses
characteristic of Ngo-infected epithelial cells, we compared
their capacity to contribute to Ngo-induced AP-1 activation.
In transient transfection assays we used PAK2 and PAK1
dominant inhibitory mutant kinases to investigate whether
PAK might be involved upstream in the Ngo-induced sig-
naling cascade leading to MKK4, JNK, and AP-1 activa-
tion. The PAK2 mutant contains a K278R and PAK1 a
K299R mutation that inactivate the catalytic activity of the
kinase domain. The mutations in the amino acids arginine
278 and 299 have been demonstrated to be important for
the kinase activity of PAKs (58). HeLa cells transfected
with DNPAK2 and treated either with adherent (P1 Opa2)
or invasive (P2 Opa1) Ngo strains for 30 min strongly re-
duced the AP-1 transactivation activity, compared to mock
transfected cells (Fig. 5 A). Similar to PAK2 we observed
reduced transactivation activity of AP-1 in transfected
DNPAK1 and Ngo-stimulated cells (data not shown). The
experiments were performed after careful titration of the
cDNAs to allow specific inhibition of the AP-1 transactiva-
tion activity. Since mammalian PAKs (PAK1, 2 and 3) ex-
ert .90% homology in their COOH-terminal kinase do-
main, they will putatively inhibit downstream signaling of
all three PAK isoenzymes. To exclude potential effects on
the putative upstream components due to titration of Rho-
GTPases, we performed experiments with a PAK1 con-
struct mutated in histidine 83 and 86, which prevent the
binding of GTPases. Using such construct, similar results as
described above were obtained (data not shown). There-
fore, these results indicate that PAK could lie upstream of
MKK4 and JNK leading to AP-1 activation. As already
shown in Fig. 2 C, nonpathogenic Ngo strain P2 Opa2
slightly induces the transactivation activity of AP-1, which
is reduced in DNPAK2-transfected cells. In PMA-treated
cells, AP-1 transactivation activity was substantially in-
creased but unaffected in DNPAK2-transfected cells (Fig.
5 A) suggesting that PMA induces JNK/AP-1 activation
via a PAK-independent pathway, as previously shown by
Rudel et al. (33).
To address the possible role of wild-type PAK in tran-
scriptional activity of AP-1 in response to Ngo (P1 Opa2),
we examined the effect of expression of PAK on the tran-
scription of an AP-1–dependent reporter construct. Over-
expression of PAK2 (wtPAK2) slightly enhanced transcrip-
tion of an AP-1–dependent reporter gene in the absence of
Ngo (Fig. 5 B). Similar data were obtained using a wild-
type PAK1 construct (data not shown). This may be in
agreement with the recent observation that the PAK acti-
vation depends on active GTPases (28) and confirms previ-
ous data showing small JNK protein kinase activity of wild-
Figure 4. Toxin B inhibits Ngo-
stimulated JNK activation. HeLa
cells were treated with Toxin B (50
ng/ml) 15 min before the infection
with Ngo strain P1 Opa2 at a MOI
of 50, with 50 nM PMA for 30 min
or left untreated, respectively (lanes
3–6). As a control, cells were left
without Toxin B (lanes 1–3). JNK1
was immunoprecipitated with an
anti-JNK1 (sc-474; Santa Cruz Bio-
technology) antibody and immunocomplex kinase activity (p-JNK1) was
determined by phosphorylation of the substrate GST-c-Jun (amino acids
1–79). First, the Western blots were probed with the anti-JNK1 antibody,
to show similar protein amounts in all lanes (bottom). In the subsequent
autoradiography the JNK1 kinase activity (p-JNK1) measured by c-Jun
substrate phosphorylation is indicated (top). The data are representative for
at least three independent experiments.
Figure 5. (A) PAK is involved in Ngo-induced AP-1–dependent tran-
scription. HeLa cells were transfected with 1 mg reporter construct and
either 0.75 mg dominant inhibitory PAK2 (DNPAK2) or empty vector.
After overnight incubation with the DNA, cells were infected with dif-
ferent Ngo strains (P1 Opa2, P2 Opa1, and P2 Opa2) at a MOI of 50 or
treated with 50 nM PMA for 30 min. The results of a representative ex-
periment are expressed as fold induction over the activity observed with
transfection of the reporter vector and empty vector and in the absence of
Ngo strains or PMA. Similar results were obtained in more than three in-
dependent experiments. (B) HeLa cells were transfected as described
above using 0.5 mg wild-type PAK2 (wtPAK2) instead of DNPAK2 and
incubated with the Ngo strain P1 Opa2 at a MOI of 50 for 30 min. The
results of a representative experiment are expressed as fold induction
compared with the activity observed with transfection of the reporter
vector and empty vector and in the absence of Ngo. Similar results were
obtained in more than three independent experiments. (C) PAK2 activa-
tion in response to Ngo-epithelial cell contact was studied for the indi-
cated periods of time in HeLa cells treated with Ngo strain P1 Opa2 at a
MOI of 100 before preparation (lanes 1–4). PAK2 was immunoprecipi-
tated with an anti-PAK2 antibody (Santa Cruz, sc-1872) and immuno-
complex kinase activity (p-PAK2) was determined by phosphorylation of
1 mg of the substrate MBP. The samples were separated by SDS-PAGE
and blotted. First, the Western blot was probed with an anti-PAK2 anti-
body, to show similar protein amounts in all lanes (bottom). The PAK2
protein is indicated. In the subsequent autoradiography the PAK2 kinase
activity (PAK2) measured by MBP substrate phosphorylation is indicated
(top). The data are representative for at least three independent experi-
ments.1282 Activation of Stress Response Kinases by N. gonorrhoeae
type PAK3 overexpression (20). In the presence of Ngo P1
Opa2 we observed an increased and additive effect on the
AP-1 transactivation activity compared to mock transfected
cells (Fig. 5 B).
To study the JNK/AP-1 activation by the kinase activity
of PAK2, we immunoprecipitated PAK2 from Ngo (P1
Opa2)-stimulated HeLa cells after the indicated periods of
time. The activity of PAK2 (p-PAK2) was induced several
fold in HeLa cells by the Ngo strain N138 (P1 Opa2; Fig.
5 C) within 15 min after infection measuring phosphoryla-
tion activity of PAK2 with MBP as a substrate. The imme-
diate PAK2 induction further increased within 45 min and
declined to a reduced activity within 90 min. The lower
panel of Fig. 5 shows the Western blot probed with an
anti-PAK2 antibody, to show similar protein amounts in all
lanes.
In an attempt to explore whether MEKK1 is involved
when Ngo bacteria induce MKK4/JNK/AP-1 activity, we
tested if inhibitory DNMEKK1 blocks this pathway. In
contrast to kinase-inactive inhibitory mutants of PAKs,
DNMEKK1 does not block Ngo-induced AP-1 transcrip-
tional activity (Fig. 6, A and B). In contrast to Ngo, PMA-
induced AP-1 transactivation activity clearly appears inhib-
ited by DNMEKK1 (Fig. 6 C). A role for PMA-activated
PKC in the activation of MEKK1 was recently described (59).
Therefore, these results indicate that PAKs do not lie up-
stream of MEKK1 in a pathway leading to AP-1 activation.
Rather, the data suggest that PAKs independently mediate
JNK/AP-1 activation in a Ngo-induced signaling pathway.
Discussion
In most pathogen infections, epithelial cells represent the
first barrier for the microorganisms in the host tissue and
could function as an early warning system that activates the
immune response using signals that lead to the attraction of
phagocytic cells (1). The activatory signaling leading to
posttranslational modification and activation of the tran-
scription factor AP-1 plays a critical role in the regulation
of proinflammatory cytokine genes and other gene pro-
moters whose gene products have immunomodulatory
functions (60). The ability to respond appropriately to such
signaling events is essential for the survival of the eukary-
otic cell. Perturbations in the normal regulation of these
specific responses can result in pathogenic events that lead
to acute or chronic disease. AP-1 transcriptional activity
and subsequent upregulation of proinflammatory cytokines
is induced upon the initial contact of Neisseria gonorrhoeae
with epithelial cells, which influence the immune surveil-
lance. Adherent P1 Ngo or invasive Opa1 Ngo induce a
rapid and specific activation of AP-1 and subsequently a
panel of cytokine genes. The physical invasion of epithelial
cells by Ngo is not a prerequisite of AP-1 activation and cy-
tokine upregulation (3). Thus, it appears that the Ngo-
eukaryotic cell contact is already sufficient to induce an ef-
ficient downstream signaling. To a better understanding of
the crucial outcome of the Ngo infection, we studied the
upstream components involved in AP-1 activation.
In this study we analyzed the capability of adherent and
invasive Ngo strains to induce stress response kinase path-
ways leading to AP-1 activation in epithelial cells. Compo-
nents of kinase cascades modulate AP-1 activation at differ-
ent control points including regulation at the transcriptional
and posttranslational level. Exposure of mammalian cells to
a variety of physiological stress stimuli, including Ngo cell
contact (3), activate the transcription factor AP-1 and many
target genes (19). Moreover, overexpression of AP-1 in re-
sponse to a variety of stress factors has been implicated in a
number of immunoinflammatory and proliferative diseases
(60). c-Jun is the central component of all AP-1 dimeric
protein complexes and phosphorylation of c-Jun in the ac-
tivation domain is exerted only by the JNKs (19). We
found that Ngo stimulates JNK in epithelial cells (Fig. 1),
which phosphorylates c-Jun at serines 63/73 (61), and AP-1–
dependent transcriptional activity (Fig. 2). The JNK kinase
activity in response to adherent (P1 Opa2) or invasive (P2
Opa1) Ngo strains, which induce a variety of proinflam-
matory cytokines, was observed rapidly within 15 min after
infection at a MOI of 50 and further increased within 90
min, whereas the nonpathogenic strain (P2 Opa2) or LPS
induced weak and no JNK activity, respectively. Our data
indicate that contact between Ngo and epithelial cells is suf-
ficient to induce an efficient downstream signaling leading
Figure 6. Ngo-induced AP-1
transcription activity does not in-
volve MEKK1. AP-1–dependent
transcription was analyzed using
HeLa cells transfected with a re-
porter construct (1 mg) and ei-
ther 1 mg dominant inhibitory
MEKK1 or empty vector. After
overnight incubation with the
DNA, cells were infected with
Ngo strain P1 Opa2 (A) or Ngo
strain P2 Opa1 (B) at a MOI of
50, or treated with 50 nM PMA
(C) for the indicated periods of
time. The results of a representa-
tive experiment are expressed as
fold induction compared with
the activity observed with trans-
fection of the reporter vector and
empty vector and in the absence
of Ngo strains or PMA. Similar
results were obtained in more
than three independent experi-
ments.1283 Naumann et al.
to the activation of cytokine genes. The TNF-a–treated
cells showed JNK activation to a similar extent, but with a
maximum within 15 min. Activation of JNK was observed
in both cell lines studied, but was at least 10 times less ef-
fective and delayed in Chang cells compared to HeLa cells.
This points to the assumption that epithelial cells are capa-
ble of responding differently to external stimuli. For exam-
ple, the opa-dependent invasion of Ngo in Chang conjunc-
tiva cells occurs irrespective of the presence of serum but
involves PLC and ASM (12). In many other epithelial cells,
this signaling pathway appears to be less prominent,
whereas the serum factor vitronectin was shown to allow
HSPR-dependent invasion (10). The observation that
JNK, but not p38 kinase was activated by Ngo suggests that
the activatory mechanisms of these kinases by this stimulus
are at least partially different. Our finding that Ngo induced
stress response kinase JNK contributing in the activation of
cytokine genes in epithelial cells is consistent with another
report on Salmonella typhimurium (62), which supports the
notion that epithelial cells are an integral component of the
host immune system. LPS does not effectively induce cy-
tokines AP-1 and JNK in epithelial cells, which could be
explained in part by lack of CD14 on epithelial cells. In
contrast to Ngo epithelial cell contact, infection of mac-
rophages by Yersinia enterocolitica suppresses the LPS-medi-
ated activation of JNK as well as p38 kinase activation (63).
Thus, different pathogen stimulants trigger multiple signal
transduction pathways in the target cell.
Stimulation of cells with epidermal growth factor (EGF;
references 43–45) or IL-1 (64) leads to JNK activation by a
pathway that involves the activation of MKK4. Like other
physiologic stress inducers (e.g. UV light and osmotic
shock; reference 2), the human pathogenic adherent (P1
Opa2) or invasive (P2 Opa1) Ngo strains also induce
MKK4, and overexpression of the kinase negative MKK4
inhibits activation of AP-1 (Fig. 2, A and B). The domi-
nant inhibitory effect of MKK4 on Ngo-induced AP-1 acti-
vation indicates that JNK is required to mediate full tran-
scriptional activation of AP-1 in response to Ngo and
suggests either the formation of a stable JNK/MKK4 com-
plex or sequestration of crucial elements immediately up-
stream of MKK4. A number of kinases have been postu-
lated to regulate the JNK/AP-1 activation. These include
the MEKKs 1, 2, and 4 (65–67) and tumor progression lo-
cus 2 (Tpl-2; reference 24), which phosphorylate and acti-
vate MKK4. Germinal center kinase (21), the mixed lin-
eage kinases (MLK), MLK2 and 3/SPRK, DLK/MUK
(23, 68–70), and TGF-b–activated kinase (22) show selec-
tivity for the activation of JNK and phosphorylate MKK4
in vitro. In contrast to other stimuli like EGF, we could
exclude that MEKK1 is involved in Ngo-induced JNK/
AP-1 activation. DNMEKK1 does not affect the pathogen-
induced  (P1 Opa2 or P2 Opa1) activation of AP-1,
whereas PMA-induced AP-1 activity, which presumably
involves activated PKC (59), is inhibited (Fig. 6, A–C).
Similar to a number of other kinases, PAKs are shown to
be activators of JNK signaling cascades (20), although PAKs
do not directly phosphorylate MKK4 (53). In Ngo-stimu-
lated cells, PAK mediates its effect on the JNK/AP-1 path-
way independent of MEKK1. The ability of DNPAKs
(DNPAK2 and DNPAK1) to block AP-1 activation by
Ngo  (P1 Opa2 or P2 Opa1), and the activation of AP-1 by
PAK (wtPAK2 and wtPAK1) overexpression and activa-
tion of endogenous PAK2 in response to Ngo (P1 Opa2)
indicate that PAK may function as a component of the
same signaling transduction pathway that leads to MKK4/
JNK and AP-1 activation (Fig. 5). In the future it will be
necessary to address which components downstream of
PAKs lead to JNK/AP-1 activation. A suggested candidate
kinase that might play such a role could be SPRK, a mixed
lineage kinase (23). p21-activated kinase is the most up-
stream component of the Rac1/Cdc42 pathway linking
these GTPases to JNK (56). By studying the involvement
of GTPases in Ngo-induced signaling, we used Toxin B
from Clostridium difficile, which specifically inhibits the ac-
tivity of the members of the Rho family (54). AP-1 tran-
scriptional activity and JNK activation is strongly reduced
in the presence of Toxin B (Fig. 3). These data indicate
that GTPases and PAKs may function as components of the
same signal transduction pathway that leads to JNK protein
kinase and the activation of the transcription factor AP-1.
From these findings, we suggest a pathway, depicted in
Fig. 7, through which human pathogenic Ngo stimulate the
JNK/AP-1 activity. Activation of GTPases by upstream
signals leads to increased activity of PAK kinase(s). PAK
does not directly phosphorylate JNK. Activation of JNK by
dual phosphorylation is mediated by MKK4, which be-
comes phosphorylated by MKKK. Thus PAKs presumably
regulate the activity of MKKK. The signaling pathway
through GTPases, PAK, MKKK, MKK4, JNK, and AP-1
are orchestrated to yield a coordinated response of cyto-
skeletal changes and transcriptional activity leading to the
release of immune response mediators.
Neisseria strains used in our experiments produce either
pili (P1) or Opa proteins (Opa1) capable of interacting
with cells, or neither pili nor Opa proteins. In phagocytes
the Opa-CD66 receptor interaction could be important for
the invasion-dependent downstream signaling involving
Src-kinases and Rac1 (16). Internalization of Opa-express-
ing Ngo in epithelial cells has been shown to be HSP-
dependent (9) and occur by at least two different mecha-
nisms. Invasion in Chang cells depends on the activation of
ASM and the second messengers diacylglycerol (DAG) and
Figure 7. Schematic presenta-
tion of the signaling leading to
JNK and AP-1 activation in re-
sponse to Ngo-epithelial cell con-
tact. The binding of Ngo to epi-
thelial cells leads to the activation
of low molecular mass GTPases
and sequential protein kinase
pathways controlling AP-1 acti-
vation. PAK activates the JNK/
AP-1 pathway involving un-
known MKKK and MKK4, but
not MEKK1.1284 Activation of Stress Response Kinases by N. gonorrhoeae
ceramide (12). In other epithelial cells including HeLa, an-
other pathway depending on the serum factor vitronectin
allows HSP-dependent invasion. Vitronectin-dependent
invasion of Opa1 Ngo (10) involves integrin receptors (11).
Vitronectin also possesses a HSP-binding site and is gener-
ally known to interact with certain integrins (71). In this
respect internalization of Ngo by epithelial cells could be
mediated by integrin-dependent endocytosis of vitronectin,
which results from interaction with heparan-sulfate pro-
teoglycans (HSPGs). Since Ngo-induced cytokines, the ac-
tivation of AP-1 (3) and stress response kinases are already
induced by noninvasive Ngo (P1 Opa2), we suggest that
Ngo adhesion activates signals leading to the activation of
immune response mediators. Thus it seems, that Ngo trig-
ger a number of signaling pathways, which are either essen-
tial for the pathogen infection, or represent the host reac-
tion in response to the pathogenic microbes.
Cytokines produced from epithelial cells represent spe-
cific modulators of the immune response and could be an
advantage in the eradication of the parasite, but could also
be a disadvantage by leading to chronic inflammatory dis-
eases instead. The ability to respond appropriately to such
signaling events is essential for the survival of the cell and
ultimately the whole organism. A chronic inflammatory
state, induction of adhesion molecules, chemotaxis and ac-
tivation of leukocytes, the production of mediators of in-
flammation and continuous T cell activation leads to self-
perpetuating destruction of the epithelial structure. All
these events are controlled at the level of transcription of
genes necessary for the production of new proteins such as
growth factors, interleukins, proteinases and cytokines.
Regulating this process, e.g., by disrupting the signal trans-
duction pathways of transcription factors, has the potential
to attenuate the production of immune response mediators,
thereby halting or reversing the course of the disease.
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